Join Now

Author Archives: Press Release

Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

By Press Release | Published August 17, 2023

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians

Posted in BioUtah News | Tagged | Comments Off on Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

This plan to cut drug prices could result in lost jobs and fewer medicines

By Press Release | Published August 17, 2023

By Kelvyn Cullimore For the Deseret News

Posted in BioUtah News | Tagged | Comments Off on This plan to cut drug prices could result in lost jobs and fewer medicines

Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

By Press Release | Published August 17, 2023

Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

By Press Release | Published August 10, 2023

Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances were made possible by NVIDIA DGX Cloud supercomputing and the recent acquisition of Cyclica’s MatchMaker technology.

Posted in BioUtah News | Tagged | Comments Off on Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery

By Press Release | Published August 10, 2023

August 7, 2023 Four years ago, Jacob Sheffield was building world-class carbon fiber travel guitars for adventurers journeying to places as remote as Everest and Antarctica. Ian Esplin was growing viruses in bioreactors and developing therapies to combat antibiotic-resistant pathogens. The two came together and co-founded Bloom Surgical with a goal to empower robotic surgeons […]

Posted in BioUtah News | Tagged | Comments Off on Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

By Press Release | Published August 10, 2023

Myriad Genetics announced enhancements to the GeneSight® Psychotropic test.

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment

By Press Release | Published August 10, 2023

ComboMATCH study uses genetic testing to match advanced cancer patients with targeted treatments

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment

Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

By Press Release | Published August 3, 2023

World leading, multi-disciplinary experts advise on adoption of FDA authorized KidneyintelX.dkd across 14 million US patients with diabetes and chronic kidney disease

Posted in BioUtah News | Tagged | Comments Off on Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

By Press Release | Published August 3, 2023

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis […]

Posted in BioUtah News | Tagged | Comments Off on Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

Alucent Biomedical Wins FDA Approval for U.S. Clinical Study

By Press Release | Published August 3, 2023

U.S. FDA Grants an Investigational Device Exemption for Trial Evaluating Novel AlucentNVS Technology

Posted in BioUtah News | Tagged | Comments Off on Alucent Biomedical Wins FDA Approval for U.S. Clinical Study

Quansys Biosciences and The Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research

By Press Release | Published August 3, 2023

Quansys Biosciences and The Michael J. Fox Foundation, announced a strategic partnership to accelerate research into PD.

Posted in BioUtah News | Tagged | Comments Off on Quansys Biosciences and The Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research

Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

By Press Release | Published July 27, 2023

RiskScore is the first validated risk model that includes breast density, personal/family history and genetic markers. This comprehensive model is expected to identify more patients that could benefit from a change in their breast care.

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

A Special Thanks To Our Elite Members